HSP90B2P and uveitis: Our findings demonstrate that this may also be true in uveitis and it opens the possibility that the blockage of endogenous produced Hsp, whose expression should be enhanced during autoimmunity, may present an interesting target for immunotherapy of this syndrome of the eye.